Condition: Post-inflammatory Hyperpigmentation · Melasma · Solar Lentigo · Sponsor: Kenvue Brands LLC
The study aims to evaluate the efficacy of a facial sunscreen under two experimental conditions-untinted and tinted-in improving facial spots (melasma and solar lentigines/post-inflammatory hyperpigmentation) after 8 weeks of product use under normal conditions by adult participants.
This description comes directly from the study's public registry record.
Kenvue Global Clinical Operations · 18779295131 · KenvueClinical_KV@kenvue.com
Always discuss trial participation with your own doctor first.
| ALS Beauty & Personal Care Ltda | Campinas, São Paulo, Brazil | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07679945